|
PLEKHA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.778400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.541300E-03 |
| Normal-vs-Stage2 |
4.520000E-01 |
| Normal-vs-Stage3 |
6.565200E-01 |
| Normal-vs-Stage4 |
9.243800E-01 |
| Stage1-vs-Stage2 |
4.569000E-01 |
| Stage1-vs-Stage3 |
4.213800E-01 |
| Stage1-vs-Stage4 |
3.492200E-01 |
| Stage2-vs-Stage3 |
9.082400E-01 |
| Stage2-vs-Stage4 |
7.160800E-01 |
| Stage3-vs-Stage4 |
8.477200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.156400E-03 |
| Normal-vs-AfricanAmerican |
9.743900E-02 |
| Normal-vs-Asian |
2.189800E-01 |
| Caucasian-vs-AfricanAmerican |
7.567600E-01 |
| Caucasian-vs-Asian |
5.914800E-01 |
| AfricanAmerican-vs-Asian |
4.592200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.83559999999661E-05 |
| Normal-vs-Female |
5.725400E-01 |
| Male-vs-Female |
4.212300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.858200E-01 |
| Normal-vs-Extreme_Weight |
5.78849999999242E-05 |
| Normal-vs-Obese |
3.017400E-01 |
| Normal-vs-Extreme_Obese |
5.838200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.688200E-01 |
| Normal_Weight-vs-Obese |
6.891800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.039200E-01 |
| Extreme_Weight-vs-Obese |
6.632400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.392200E-01 |
| Obese-vs-Extreme_Obese |
9.866000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.491600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.625500E-02 |
| Normal-vs-Age(61-80Yrs) |
9.897100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.634840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.636200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.018400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.668600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.330000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.551600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.977200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.142100E-03 |
| Normal-VS-Type2 PRCC |
2.162000E-01 |
| Normal-VS-KIRP CIMP |
3.552000E-01 |
| Normal-VS-Unclassified PRCC |
1.401800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.986200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.772400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.714000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.491200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.172000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.337900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.379930E-04 |
| Normal-vs-N1 |
6.372200E-01 |
| Normal-vs-N2 |
2.975000E-01 |
| N0-vs-N1 |
5.615600E-02 |
| N0-vs-N2 |
5.354000E-02 |
| N1-vs-N2 |
9.195200E-01 |
|
|
